Replies to Post #18749 onXcelerate Inc (XCRT)

Replies to #18749 on Xcelerate Inc (XCRT)

08/01/22 9:21 AM

#18750 RE: i_like_bb_stock #18749

Xcelerate, Inc. Announces Uplisting to OTCQB Market
Press Release | 08/01/2022
MAULDIN, SC / ACCESSWIRE / August 1, 2022 / Xcelerate, Inc. (OTCQB:XCRT), today announces that the OTC Market Group has approved the Company's application for uplisting to the OTCQB® Venture Market (the "OTCQB"). The Company will commence trading on the OTCQB with the market open on August 1, 2022, under the symbol "XCRT"

Xcelerate, Wednesday, June 22, 2022, Press release picture
"Trading on OTCQB is an important achievement for our Company. We believe it will provide increased transparency and improved liquidity to both existing and prospective shareholders," said Michael O'Shea, Chief Executive Officer of Xcelerate, Inc. "Our plans include continuing with our corporate growth through the balance of this year and beyond. We believe listing on the OTCQB will allow our story to reach a wider investor audience, a key objective for the Company in 2022. I would like to thank our partners and investors for their continued support as we continue to execute on our business plan."

OTCQB is operated by OTC Markets Group, Inc. and is designed for early-stage and developing companies in the United States and abroad. To be eligible for OTCQB quotes, companies must be current in their disclosure filings, have audited financial statements, and undergo an annual validation and management certification process. Companies must also meet minimum bid testing and other financial terms. OTCQB is recognized as an established public market by the Securities and Exchange Commission ("SEC") and provides current public information to investors in need of securities analysis, valuation, and trading.

ABOUT XCELERATE INC.

In May 2020, Xcelerate commenced implementation of a new business plan that encompasses two separate but related businesses within the medical industry, including (i) owning and licensing the rights to various forms of medical equipment and portfolio of patents, patents pending and technology licenses and (ii) development of virtual health technology to assist patients in developing countries obtain medical care by extending the reach of physicians through the use of that technology. Visit www.xcelerate.global to learn more.